切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2021, Vol. 07 ›› Issue (04) : 326 -330. doi: 10.3877/cma.j.issn.2096-1537.2021.04.008

临床研究

不同碳水化合物肠内营养液对应激性高血糖患者早期血糖水平与预后的影响
臧玉柱1, 杨小雪1, 李丽2, 卓越2, 叶英2,()   
  1. 1. 221002 徐州医科大学附属医院急救中心(急诊科)
    2. 221002 徐州医科大学附属医院急救中心(急诊科);221002 徐州医科大学江苏省卫生应急研究所
  • 收稿日期:2021-07-08 出版日期:2021-11-28
  • 通信作者: 叶英

Effects of different carbohydrate enteral nutrient solutions on blood glucose level and prognosis of patients with stress hyperglycemia in early nutrition

Yuzhu Zang1, Xiaoxue Yang1, Li Li2, Yue Zhuo2, Ying Ye2,()   

  1. 1. Emergency Center of the Affialited Hospital, Xuzhou Medical University, Xuzhou 221002, China
    2. Emergency Center of the Affialited Hospital, Xuzhou Medical University, Xuzhou 221002, China; Jiangsu Institute of Health Emergency Response, Xuzhou Medical University, Xuzhou 221002, China
  • Received:2021-07-08 Published:2021-11-28
  • Corresponding author: Ying Ye
引用本文:

臧玉柱, 杨小雪, 李丽, 卓越, 叶英. 不同碳水化合物肠内营养液对应激性高血糖患者早期血糖水平与预后的影响[J/OL]. 中华重症医学电子杂志, 2021, 07(04): 326-330.

Yuzhu Zang, Xiaoxue Yang, Li Li, Yue Zhuo, Ying Ye. Effects of different carbohydrate enteral nutrient solutions on blood glucose level and prognosis of patients with stress hyperglycemia in early nutrition[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2021, 07(04): 326-330.

目的

观察不同的碳水化合物肠内营养液[肠内营养乳剂(TPF-D)和肠内营养混悬液(TPF)]用于早期肠内营养对应激性高血糖患者血糖水平与预后的影响,探讨其作为应激性高血糖患者早期肠内营养制剂的临床可行性。

方法

选入2020年6至10月徐州医科大学附属医院急诊ICU收治的合并应激性高血糖的患者为研究对象。根据入排标准,最终71例患者纳入研究,随机数字表法将其分为观察组(35例,鼻饲TPF-D)和对照组(36例,鼻饲TPF)。收集患者一般资料,包括性别、年龄、急性生理与慢性健康状况(APACHE Ⅱ)评分;记录患者第1、3、7天每4小时一次血糖数据,并计算平均血糖值(GLUAVE)、平均血糖波动幅度(GLUMAGE);计算治疗后3、7 d胰岛素应用总量;监测患者第1、7天相关营养指标变化,如总蛋白(TP)、白蛋白(ALB)、前白蛋白(PA);记录胃肠道并发症(如反流、呕吐、腹泻、腹胀等)、ICU住院时间及28 d病死率。

结果

(1)2组性别比例、年龄、APACHE Ⅱ评分比较,差异均无统计学意义(P>0.05)。(2)2组第1、3、7天GLUAVE及第1、3天GLUMAGE比较,差异均无统计学意义(P>0.05);观察组第7天GLUMAGE显著低于对照组,差异有统计学意义[(0.72±0.08)mmol/L vs(1.56±0.10)mmol/L,t=6.22,P=0.02]。(3)观察组治疗3、7 d胰岛素应用总量显著低于对照组,差异均有统计学意义[(60.40±39.80)U vs(102.70±49.60)U,t=0.17,P=0.02;(110.50±43.30)U vs(202.80±56.40)U,t=2.52,P=0.01]。(4)2组第1、7天TP、PA、ALB比较,差异均无统计学意义(P>0.05)。(5)2组胃肠道并发症、ICU住院时间、28 d病死率比较,差异均无统计学意义(P>0.05)。

结论

应激性高血糖患者早期营养中,TPF-D较TPF能更好地降低血糖变异性,控制血糖波动幅度,并减少临床中胰岛素用量,但不影响预后。

Objective

To observe the effects of enteral nutritional emulsion (TPF-D) on blood glucose level and prognosis in patients with stress hyperglycemia during early nutrition, and to explore the clinical feasibility of TPF-D as Enteral nutrition preparation in patients with stress hyperglycemia.

Methods

Eighty-five patients with stress hyperglycemia admitted to the Emergency ICU of the Affiliated Hospital of Xuzhou Medical University from June 2020 to October 2020 were selected as the research subjects, 71 of whom were eventually enrolled. The enrolled patients were divided into observation group and control group according to random number table method. 35 cases of nasal feeding TPF-D were the observation group, and 36 cases of nasal feeding TPF were the control group. General data of 2 groups were collected, including gender, age, acute physiology and chronic health evaluation (APACHE Ⅱ). Blood glucose data of patients admitted to ICU for days 1, 3 and 7 every 4 hours were recorded, and average blood glucose (GLUAVE) and mean amplitude of glycemic excursions (GLUMAGE) were calculated. The total amount of insulin at 3 and 7 days after treatment was calculated. The changes of related nutritional indexes of patients on day 1 and 7 were monitored, including total protein (TP), albumin (ALB) and prealbumin (PA). Gastrointestinal complications (such as regurgitation, vomiting, diarrhea, abdominal distention, etc.), length of ICU stay, and 28-day mortality were recorded as well.

Results

(1) Sex ratio, age, APACHE Ⅱ scores between observation group and control group, showed no significant difference (P>0.05). (2) The GLUAVE of the observation group and the control group on days 1, 3, 7, and GLUMAGE on days 1, 3, were not significantly different (P>0.05). GLUMAGE in the observation group was significantly lower than that in the control group on day 7 [(0.72±0.08) mmol/L vs (1.56±0.10) mmol/L, t=6.22, P=0.02]. (3) The total amount of insulin in the observation group and the control group at days 3, 7 after treatment were statistically significant [day 3: (60.40±39.80) U vs (102.70±49.60) U, t=0.17, P=0.02; day 7:(110.50±43.30) U vs (202.80±56.40) U, t=2.52, P=0.01]. (4) Compared with the control group on day 1, TP, PA and ALB had no significant changes (P>0.05). (5) The gastrointestinal complications, length of ICU stay, 28-day mortality between two groups had no significant differences (P>0.05).

Conclusion

In the early nutrition of stress hyperglycemia patients, TPF-D can better reduce the variability of blood glucose, control the fluctuation range of blood glucose, and reduce the clinical dose of insulin, but it does not affect the prognosis.

表1 2组患者一般情况比较(
xˉ
±s)
表2 2组GLUAVE、GLUMAGE和使用胰岛素总量比较(
xˉ
±s)
表3 2组TP、ALB、PA等营养指标比较(g/L,
xˉ
±s)
表4 2组患者胃肠道并发症及ICU住院时间、28 d病死率比较
1
Merlino G, Smeralda C, Gigli GL, et al. Stress hyperglycemia is predictive of worse outcome in patients with acute ischemic stroke undergoing intravenous thrombolysis [J]. J Thromb Thrombolysis, 2021, 51(3): 789-797.
2
Olariu E, Pooley N, Danel A, et al. A systematic scoping review on the consequences of stress-related hyperglycaemia [J]. PLoS One, 2018, 13(4): 194-195.
3
Pieralli F, Bazzini C, Fabbri A, et al. The classification of hospitalized patients with hyperglycemia and its implication on outcome: results from a prospective observational study in internal medicine [J]. Intern Emerg Med, 2016, 11(5): 649-656.
4
闫凯旋, 曹铖, 杨磊, 等. 糖尿病专用型肠内营养混悬液对重型脑损伤患者营养指标以及免疫功能的影响 [J]. 肠外与肠内营养, 2018, 25(2): 76-80.
5
江华. 危重症患者的应激性高血糖、营养治疗与血糖管理 [J]. 中华糖尿病杂志, 2015, 7(2): 71-72.
6
万献尧, 于凯江, 马晓春, 等. 中国重症加强治疗病房危重患者营养支持指导意见(2006) [J]. 中华外科杂志, 2006, 44(17): 1167-1177.
7
McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient [J]. JPEN J Parenter Enteral Nutr, 2016, 40(2): 159-211.
8
Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive care unit [J]. Clin Nutr, 2019, 38(1): 48-79.
9
Moorthy V, Sim MA, Liu W, et al. Risk factors and impact of postoperative hyperglycemia in nondiabetic patients after cardiac surgery: A prospective study [J]. Medicine (Baltimore), 2019, 98(23): 1-6.
10
Jivanji CJ, Asrani VM, Windsor JA, et al. New-onset diabetes after acute and critical illness: a systematic review [J]. Mayo Clin Proc, 2017, 92(5): 762-773.
11
连丽华. 危重症高血糖患者进行血糖护理干预的效果及对预后的影响分析 [J]. 中国卫生标准管理, 2017, 8(16): 159-160.
12
Mifsud S, Schembri EL, Gruppetta M. Stress-induced hyperglycaemia [J]. Br J Hosp Med (Lond), 2018, 79(11): 634-639.
13
Luo JX, Qu YM, Zhang QY, et al. Relationship of glucose variability with glycated hemoglobin and daily mean glucose: a post hoc analysis of data from 5 phase 3 studies [J]. J Diabetes Sci Technol, 2018, 12(2): 325-332.
14
Chao WC, Tseng CH, Wu CL, et al. Higher glycemic variability within the first day of ICU admission is associated with increased 30-day mortality in ICU patients with sepsis [J]. Ann Intensive Care, 2020, 10(1): 259-272.
15
康福新, 王小智. 血糖变异度在重症急性胰腺炎预后评估中的临床研究 [J]. 中国急救医学, 2017, 37(5): 443-446.
16
Monnier L, Colette C, Boegner C, et al. Continuous glucose monitoring in patients with type 2 diabetes: Why? When? Whom? [J]. Diabetes Metab , 2007, 33(4): 247-252.
17
Jeremy C, Salim S. Glucose control in critical care [J]. World J Diabetes, 2015, 6(9): 1082-1091.
18
张馨, 衡卫卫, 李姗姗, 等.新型糖尿病肠内营养制剂改善急性重症缺血性脑卒中患者的血糖和胰岛素抵抗状态 [J]. 肠外与肠内营养, 2016, 23(6): 342-345.
19
Dos SL, Souto DL, Rodacki M, et al. Metabolic and appetite effects of fructose and glucose in subjects with type 1 diabetes: a randomized crossover clinical trial [J]. Curr Diabetes Rev, 2020, 17(6): 21-30.
20
Alfonso M, Juan C, Clara V, et al. Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study [J]. Crit Care, 2015, 19(1): 11-23.
[1] 章宇潇, 杨凡, 毛萌. 《生长减缓婴幼儿的追赶性生长:指导普通临床医师的专家共识(2023版)》解读[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 361-366.
[2] 吴越廷, 周林雨涵, 胡钦, 许华燕, 黄敏, 陈晓勇, 张萌, 李中会, 茹凉, 王秋, 蔡晓唐. 皮质类固醇治疗非卧床杜氏肌营养不良症患儿肺功能与运动功能的纵向研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 292-301.
[3] 孙勇, 彭曦. 重视烧伤创面愈合中的葡萄糖代谢以优化营养治疗策略[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(04): 277-281.
[4] 白浪, 张雪玉, 白铁成, 贺爱军. 腹腔镜近端胃切除术中圆锥形重叠吻合成形术对Siewert Ⅱ型AEG患者胃食管反流、营养状态的影响研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 679-682.
[5] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[6] 翟刚, 邓修民, 岑川, 黄锋, 黄显壮, 王运成. 改良双通道吻合法在完全腹腔镜近端胃切除术中的临床效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 397-400.
[7] 王铭池, 梁乐琦, 刘永达. 基于NHANES数据库分析血脂与肾结石之间的关系[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 485-490.
[8] 黄海, 程必盛, 黄健. 2024年欧洲泌尿外科学会年会:前列腺癌研究的前沿探索与未来趋势[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 202-207.
[9] 周慧宇, 吕定阳, 双卫兵. 联合系统性免疫炎症指数和预后营养指数预测腹腔镜肾切除术后肾癌患者的预后[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 225-231.
[10] 龚财芳, 赵俊宇, 游川. 围手术期肠内营养在肝癌肝切除患者中有效性及安全性的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 551-556.
[11] 张晓青, 唐雯. 基于临床化验指标重新计算的生物标记物在预测腹膜透析患者预后中的作用研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(04): 213-218.
[12] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[13] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[14] 宋燕秋, 戚桂艳, 杨双双, 周萍. 重症急性胰腺炎肠道菌群特征及早期肠内营养联合微生态制剂治疗的临床价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 442-447.
[15] 唐小久, 胡曼, 许必君, 肖亚. 肥胖合并胃食管反流病患者严重程度与其焦虑抑郁及营养状态的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 360-364.
阅读次数
全文


摘要